Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |